Blood from young adults is being trialled as a treatment for Parkinson’s disease by a firm that wants to use the therapy to target neurodegenerative conditions.
Alkahest, a firm co-founded by Tony Wyss-Coray of Stanford University, California, has already tested blood-based treatments in people with Alzheimer’s disease. In the latest trial, 90 people with Parkinson’s – mostly in their 70s and 80s – will receive injections five days in a row, and then again three months later.
